Morning Overview on MSN
The FDA just approved Auvelity for Alzheimer-related agitation — the first non-antipsychotic ever cleared for the hardest behavioral symptom families have to man…
Families caring for someone with Alzheimer’s disease now have a second FDA-cleared drug for agitation, and for the first time ...
Amyloid is increasingly ceding ground in Alzheimer’s disease R&D to new approaches targeting inflammation, immune processes, ...
In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801. Researchers had just released topline results of a study of more than 300 people age ...
A new pill for those genetically at risk for Alzheimer’s has shown benefits in clinical trials. FotografiaBasica/Getty Images One gene variant that is particularly associated with Alzheimer’s disease ...
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo. Reading time 4 minutes Two of the most anticipated studies this ...
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results